1. 171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer. (10th December 2020) Authors: Nagasawa, Maho; Bos, Remco; Zuo, Haoxiao; Wang Yin, Kiave Yune Ho; Lierop, Marie-José van; Tabruyn, Sebastien; Manting, Erik; Bruyn, Marco de; Nijman, Hans; Singh, Satwinder KAur; Singh, Satwinder Kaur Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 171 Preclinical studies support therapeutic application of the leukemic cell-based cancer relapse vaccine DCP-001 in ovarian cancer. (9th November 2020) Authors: Nagasawa, Maho; Bos, Remco; Zuo, Haoxiao; Wang Yin, Kiave Yune Ho; Lierop, Marie-José van; Tabruyn, Sebastien; Manting, Erik; Bruyn, Marco de; Nijman, Hans; Singh, Satwinder KAur; Singh, Satwinder Kaur Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A185 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cigarette smoke up‐regulates PDE3 and PDE4 to decrease cAMP in airway cells. (3rd June 2018) Authors: Zuo, Haoxiao; Han, Bing; Poppinga, Wilfred J; Ringnalda, Lennard; Kistemaker, Loes E M; Halayko, Andrew J; Gosens, Reinoud; Nikolaev, Viacheslav O; Schmidt, Martina Journal: British journal of pharmacology Issue: Volume 175:Number 14(2018) Page Start: 2988 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Function of cAMP scaffolds in obstructive lung disease: Focus on epithelial‐to‐mesenchymal transition and oxidative stress. (18th March 2019) Authors: Zuo, Haoxiao; Cattani‐Cavalieri, Isabella; Valença, Samuel Santos; Musheshe, Nshunge; Schmidt, Martina Journal: British journal of pharmacology Issue: Volume 176:Number 14(2019) Page Start: 2402 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗